Dermal expression of laminin-332 and type IV collagen in humans with severe sepsis

Background An intact basement membrane at the dermal–epidermal junction is essential to the viability of the skin. The effect of sepsis on the basement membrane is unknown. Methods Skin biopsies were used to study basement membrane structure in severe sepsis (Day 1). Subsequent biopsies were taken o...

Full description

Saved in:
Bibliographic Details
Published inActa anaesthesiologica Scandinavica Vol. 59; no. 8; pp. 1009 - 1014
Main Authors Koskela, M., Gäddnäs, F., Koivukangas, V., Oikarinen, A., Laurila, J., Kallioinen, M., Ala-Kokko, T. I.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.09.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background An intact basement membrane at the dermal–epidermal junction is essential to the viability of the skin. The effect of sepsis on the basement membrane is unknown. Methods Skin biopsies were used to study basement membrane structure in severe sepsis (Day 1). Subsequent biopsies were taken on Day 8 and at 3 months in the survivors. Immunohistochemical staining was undertaken using laminin‐223 and type IV collagen. Twenty patients with severe sepsis and four control subjects were included in the analysis. Results Intensive care unit mortality was 4/20, and total 30‐day mortality was 5/20. Exactly, 7/17 of patients with severe sepsis exhibited weak or absent laminin‐332 expression and 11/15 exhibited weak or absent type IV collagen expression compared with 0/4 of control subjects on Day 1 in intact skin. The proportion of sepsis patients with weak or absent laminin‐332 expression was 5/11 on Day 8 and fell to 1/7 at 3 months. The proportion of sepsis patients with weak or absent type IV collagen expression was 10/11 on Day 8 and 4/7 at 3 months. Conclusion These findings suggest that basement membrane formation may be compromised in patients with severe sepsis.
Bibliography:ArticleID:AAS12539
Oulu University Hospital EVO grant
istex:966C9F7091736BC6F978503C86F83FFC5FE4ADC4
Kainuu Central Hospital EVO grant
ark:/67375/WNG-91TDZ4JQ-P
Conflicts of interest
The authors have no conflicts of interest.
Funding
This study was financially supported by Kainuu Central Hospital EVO grant and Oulu University Hospital EVO grant.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:0001-5172
1399-6576
DOI:10.1111/aas.12539